These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 30056534)
21. Does self-perceived mood predict more variance in cognitive performance than clinician-rated symptoms in schizophrenia? Halari R; Mehrotra R; Sharma T; Kumari V Schizophr Bull; 2006 Oct; 32(4):751-7. PubMed ID: 16760421 [TBL] [Abstract][Full Text] [Related]
22. Effects of environmental noise on cognitive (dys)functions in schizophrenia: A pilot within-subjects experimental study. Wright B; Peters E; Ettinger U; Kuipers E; Kumari V Schizophr Res; 2016 May; 173(1-2):101-8. PubMed ID: 27017491 [TBL] [Abstract][Full Text] [Related]
23. Executive attention deficits in schizophrenia: putative mandatory and differential cognitive pathology domains in medicated schizophrenia patients. Meiron O; Hermesh H; Katz N; Weizman A Psychiatry Res; 2013 Aug; 209(1):1-8. PubMed ID: 23102537 [TBL] [Abstract][Full Text] [Related]
24. Cognitive impairments associated with formal thought disorder in people with schizophrenia. Kerns JG; Berenbaum H J Abnorm Psychol; 2002 May; 111(2):211-24. PubMed ID: 12003444 [TBL] [Abstract][Full Text] [Related]
25. Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia. Asevedo E; Gadelha A; Noto C; Mansur RB; Zugman A; Belangero SI; Berberian AA; Scarpato BS; Leclerc E; Teixeira AL; Gama CS; Bressan RA; Brietzke E J Psychiatr Res; 2013 Oct; 47(10):1376-82. PubMed ID: 23806580 [TBL] [Abstract][Full Text] [Related]
26. In schizophrenia, immune-inflammatory pathways are strongly associated with depressive and anxiety symptoms, which are part of a latent trait which comprises neurocognitive impairments and schizophrenia symptoms. Almulla AF; Al-Rawi KF; Maes M; Al-Hakeim HK J Affect Disord; 2021 May; 287():316-326. PubMed ID: 33812245 [TBL] [Abstract][Full Text] [Related]
27. Similar verbal memory impairments in schizophrenia and healthy aging. Implications for understanding of neural mechanisms. Silver H; Bilker WB Psychiatry Res; 2015 Mar; 226(1):277-83. PubMed ID: 25639372 [TBL] [Abstract][Full Text] [Related]
28. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
29. Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia. Kanchanatawan B; Sriswasdi S; Maes M Metab Brain Dis; 2019 Feb; 34(1):267-282. PubMed ID: 30467771 [TBL] [Abstract][Full Text] [Related]
30. Cognitive psychopathology in Schizophrenia: Comparing memory performances with Obsessive-compulsive disorder patients and normal subjects on the Wechsler Memory Scale-IV. Cammisuli DM; Sportiello MT Psychiatr Danub; 2016 Jun; 28(2):118-26. PubMed ID: 27287785 [TBL] [Abstract][Full Text] [Related]
31. Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition. Kanchanatawan B; Thika S; Anderson G; Galecki P; Maes M Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):168-176. PubMed ID: 28666826 [TBL] [Abstract][Full Text] [Related]
32. Sustained attention and positive formal thought disorder in schizophrenia. Pandurangi AK; Sax KW; Pelonero AL; Goldberg SC Schizophr Res; 1994 Sep; 13(2):109-16. PubMed ID: 7986767 [TBL] [Abstract][Full Text] [Related]
33. [Neurobiological foundations of thought and language disorder in schizophrenia]. Kircher T Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S24-32. PubMed ID: 18461541 [TBL] [Abstract][Full Text] [Related]
35. Episodic memory and executive functioning in currently depressed patients compared to healthy controls. Pauls F; Petermann F; Lepach AC Cogn Emot; 2015; 29(3):383-400. PubMed ID: 24828417 [TBL] [Abstract][Full Text] [Related]
36. Increased serum levels of eotaxin/CCL11 in late-stage patients with bipolar disorder: An accelerated aging biomarker? Panizzutti B; Gubert C; Schuh AL; Ferrari P; Bristot G; Fries GR; Massuda R; Walz J; Rocha NP; Berk M; Teixeira AL; Gama CS J Affect Disord; 2015 Aug; 182():64-9. PubMed ID: 25973785 [TBL] [Abstract][Full Text] [Related]
37. Mental state attribution, neurocognitive functioning, and psychopathology: what predicts poor social competence in schizophrenia best? Brüne M; Abdel-Hamid M; Lehmkämper C; Sonntag C Schizophr Res; 2007 May; 92(1-3):151-9. PubMed ID: 17346931 [TBL] [Abstract][Full Text] [Related]
38. Self-reported empathy deficits are uniquely associated with poor functioning in schizophrenia. Smith MJ; Horan WP; Karpouzian TM; Abram SV; Cobia DJ; Csernansky JG Schizophr Res; 2012 May; 137(1-3):196-202. PubMed ID: 22321668 [TBL] [Abstract][Full Text] [Related]
39. Association of transcription factor 4 (TCF4) gene mRNA level with schizophrenia, its psychopathology, intelligence and cognitive impairments. Alizadeh F; Tavakkoly-Bazzaz J; Bozorgmehr A; Azarnezhad A; Tabrizi M; Shahsavand Ananloo E J Neurogenet; 2017 Dec; 31(4):344-351. PubMed ID: 29105523 [TBL] [Abstract][Full Text] [Related]
40. Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity. Maes M; Sirivichayakul S; Matsumoto AK; Maes A; Michelin AP; de Oliveira Semeão L; de Lima Pedrão JV; Moreira EG; Barbosa DS; Geffard M; Carvalho AF; Kanchanatawan B Mol Neurobiol; 2020 May; 57(5):2333-2345. PubMed ID: 32040834 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]